Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: The role of telomerase activity in synovial proliferation

Arthritis and Rheumatism

Volumn 42, Issue 4, 1999, Pages 669-677

  Yudoh, Kazuo ^a   Matsuno, Hiroaki ^a   Nezuka, Takeshi ^a   Kimura, Tomoatsu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; TELOMERASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; JOINT INJURY; LYMPHOCYTIC INFILTRATION; MALE; OSTEOARTHRITIS; PATHOGENESIS; PIGMENTED VILLONODULAR SYNOVITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DNA PROBES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; SYNOVIAL MEMBRANE; SYNOVITIS, PIGMENTED VILLONODULAR; TELOMERASE;

EID: 0032927857     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199904)42:4<669::AID-ANR9>3.0.CO;2-V     Document Type: Article

References (41)

1. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
2. Harly CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990;345:458-60.
3. Levy MZ, Allsopp RC, Futcher B, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992;225:951-60.
4. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992;89:10114-8.
5. Shay JW, Wright WE, Brasiskyte D, van der Haegen BA. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 1993;8:1407-13.
6. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271-82.
7. Lindsey J, McGill N, Lindsey LA, Green DK, Cooke HJ. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991;256: 45-8.
8. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993;52:661-7.
9. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59:521-9.
10. Counter CM, Avillion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
11. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
12. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315-20.
13. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-6.
14. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-94.
15. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A 1994;91:2900-4.
16. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama L, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
17. Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G. Telomerase activity in human renal cell carcinoma. Oncogene 1996;13: 161-6.
18. Engelhardt M, Drullinsky P, Guillen J, Moore MAS. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997; 3:1931-41.
19. Clark GM, Osborne CK, Levitt D, Wu F, Kim NW. Telomerase activity and survival of patients with node-positive breast cancer. J Natl Cancer Inst 1997;89:1874-81.
20. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Mieczyslaw A, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-5.
21. Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Commun 1996;219:649-55.
22. Weng N-P, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996;183:2471-9.
23. Firestein GS. Rheumatoid synovitis and pannus. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby; 1998. p. 1-24.
24. Flandry F, Hughston JC. Pigmented villonodular synovitis. J Bone Joint Surg Am 1987;69-A:942-9.
25. Flandry F, Hughston JC, McCann SB, Kurtz DM. Diagnostic features of diffuse pigmented villonodular synovitis of the knee. Clin Orthop Rel Res 1994;298:212-20.
26. Convery FR, Lyon R, Lavernia C. Pigmented villonodular synovitis. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby; 1998. p. 1-3.
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
28. Tsai C, Diaz LA Jr, Singer NG, Li LL, Kirsch AH, Mitra R, et al. Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes. Arthritis Rheum 1996;39:125-36.
29. Takeba Y, Suzuki N, Takeno M, Asai T, Tsuboi S, Hoshino T, et al. Modulation of synovial cell function by somatostatin in patients with rheumatoid arthritis. Arthritis Rheum 1997;40: 2128-38.
30. Kiener HP, Baghestanian M, Dominkus M, Walchshofer S, Ghannadan M, Willheim M, et al. Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis. Arthritis Rheum 1998;41:233-45.
31. Rooney M, Condell D, Quinlan W, Daly L, Whelan A, Feighery C, et al. Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum 1988;31:956-63.
32. Yamanishi Y, Hiyama K, Maeda H, Ishioka S, Murakami T, Hiyama E, et al. Telomerase activity in rheumatoid synovium correlates with the mononuclear infiltration level and disease aggressiveness of rheumatoid arthritis. J Rheumatol 1998:25:214-20.
33. Norrback K-F, Dahlenborg K, Carlsson R, Ross G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 1996;88:222-9.
34. Schroder AE, Greiner A, Seyfert C, Berek C. Differentiation of B-cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid-arthritis. Proc Natl Acad Sci U S A 1996;93:221-5.
35. Cush JJ, Pietschmann P, Oppenheimer-Marks N, Lipsky PE. The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium. Arthritis Rheum 1992;35: 1434-44.
36. Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello A. Human recombinant interleukin-1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986;77:645-8.
37. Houssiau FA, Devogelaer J-P, van Damme J, de Deuxchaisnes CN, van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988;31:784-8.
38. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990;86:1780-8.
39. Lamgford LA, Piatyszek MA, Schold SCJ, Shay JW. Telomerase activity in human brain tumors. Lancet 1995:346:1267-8.
40. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995:1:249-55.
41. Nakatani K, Yoshimi N, Mori H, Yoshimura S, Sakai H, Shinoda J. The significant role of telomerase activity in human brain tumors. Cancer 1997;80:471-6.